TrovaGene Inc is rated BULL 8, indicating a sharp, short-term rally in the context of an intermediate bear market pullback. This multitrend configuration can create a whipsaw zone between intermediate resistance and short-term support as uncertainty about the continued viability of the intermediate downtrend awaits resolution. A move above intermediate resistance at 5.60 would signal an end to the intermediate pullback and resumption of the bull market, whereas a decline below short-term support at 4.97 would resume the bull market pullback with a downside target of 4.80, which is long-term support.
No Name Bashing, but he was Never a Strong Holder Anyway! Flipper like a Few Here!
Which is Fine...
The Coming 4,709% Windfall from the Tiny "Future of Medicine" Firm
Dear Private Briefing Reader,
Hello, this is Bill Patalon.
Welcome to Private Briefing.
Today, I’m so excited to share with you a company that has created what I believe could be the biggest medical revolution of this decade.
In fact, this single firm’s technology is so unique and paradigm shifting, it’s on the verge of changing medicine forever.
That’s because they’ve developed a non-invasive, non-surgical “Early Warning System” for one of the deadliest diseases on earth – cancer.
That means this technology is not only game-changing – it’s life-changing.
The system can detect cancer months, and in some cases even years, before the disease fully metastasizes.
Think about the impact this kind of Early Warning System can make fighting cancer.
Every year an estimated 1.7 new cancer cases are diagnosed – and nearly 600,000 deaths are reported.
In fact, cancer is the second-leading cause of death in the U.S., followed only by heart disease, for the past two decades.
And it’s not just about how deadly cancer is.
Today, cancer costs the global economy more money than any other disease known to man.
According to the American Institute of Cancer Research (AICR), cancer costs nearly $895 billion annually. Compare that to heart disease costing $753 billion.
Nothing else comes close, traffic accidents and diabetes – the subsequent leading causes of death – costs only $408 billion combined.
A big part of the cancer costs comes from surgical biopsy, the decades old way to make a definite diagnosis, where doctors physically remove tissue from your body.
These kinds of surgeries are not only frightening they can be incredibly painful.
Continues next post
Getting Ready to Break Out!
Flash Spike is Possible!
TROV is Still Unknown!
Not for too Much Longer!
Tiny Trading Float To Boot Too!
But, You're Waiting to Sell?
From You're Other Post!
IBB is not in Sync with TROV
If You're Long?
Pocket Change is Stupid Money!
Miss a Buy Out Opportunity!